Theranostics in nuclear medicine practice
A Yordanova, E Eppard, S Kürpig… - OncoTargets and …, 2017 - Taylor & Francis
The importance of personalized medicine has been growing, mainly due to a more urgent
need to avoid unnecessary and expensive treatments. In nuclear medicine, the theranostic …
need to avoid unnecessary and expensive treatments. In nuclear medicine, the theranostic …
Targeted radionuclide therapy of human tumors
SV Gudkov, NY Shilyagina, VA Vodeneev… - International journal of …, 2015 - mdpi.com
Targeted radionuclide therapy is one of the most intensively developing directions of nuclear
medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy …
medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy …
[HTML][HTML] Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs
Theranostics is an emerging paradigm that combines imaging and therapy in order to
personalize patient treatment. In nuclear medicine, this is achieved by using …
personalize patient treatment. In nuclear medicine, this is achieved by using …
Theranostic approaches in nuclear medicine: current status and future prospects
L Filippi, A Chiaravalloti, O Schillaci… - Expert review of …, 2020 - Taylor & Francis
Introduction: Theranostics is an emerging field in which diagnosis and specific targeted
therapy are combined to achieve a personalized treatment approach to the patient. In …
therapy are combined to achieve a personalized treatment approach to the patient. In …
How rapid advances in imaging are defining the future of precision radiation oncology
L Beaton, S Bandula, MN Gaze, RA Sharma - British journal of cancer, 2019 - nature.com
Imaging has an essential role in the planning and delivery of radiotherapy. Recent advances
in imaging have led to the development of advanced radiotherapy techniques—including …
in imaging have led to the development of advanced radiotherapy techniques—including …
Guidelines on nuclear medicine imaging in neuroblastoma
Z Bar-Sever, L Biassoni, B Shulkin, G Kong… - European journal of …, 2018 - Springer
Nuclear medicine has a central role in the diagnosis, staging, response assessment and
long-term follow-up of neuroblastoma, the most common solid extracranial tumour in …
long-term follow-up of neuroblastoma, the most common solid extracranial tumour in …
[18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma
P Wang, T Li, Z Liu, M Jin, Y Su, J Zhang, H Jing… - European Journal of …, 2023 - Springer
Purpose Iodine 123 labeled meta-iodobenzylguanidine ([123I] MIBG) scan with SPECT/CT
imaging is one of the most commonly used imaging modalities in the evaluation of …
imaging is one of the most commonly used imaging modalities in the evaluation of …
Nuclear medicine imaging in neuroblastoma: current status and new developments
A Samim, GAM Tytgat, G Bleeker, STM Wenker… - Journal of Personalized …, 2021 - mdpi.com
Neuroblastoma is the most common extracranial solid malignancy in children. At diagnosis,
approximately 50% of patients present with metastatic disease. These patients are at high …
approximately 50% of patients present with metastatic disease. These patients are at high …
EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
J Gear, C Chiesa, M Lassmann, PM Gabiña, J Tran-Gia… - EJNMMI physics, 2020 - Springer
The purpose of the EANM Dosimetry Committee Series on “Standard Operational
Procedures for Dosimetry”(SOP) is to provide advice to scientists and clinicians on how to …
Procedures for Dosimetry”(SOP) is to provide advice to scientists and clinicians on how to …
Dosimetry in clinical radiopharmaceutical therapy of cancer: practicality versus perfection in current practice
N Pandit-Taskar, A Iravani, D Lee… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The use of radiopharmaceutical therapies (RPTs) in the treatment of cancers is growing
rapidly, with more agents becoming available for clinical use in last few years and many new …
rapidly, with more agents becoming available for clinical use in last few years and many new …